Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Lancet Glob Health. 2017 Apr;5(4):e418–e427. doi: 10.1016/S2214-109X(17)30076-1

Figure 2. Proportions of children younger than 5 years with fever and Plasmodium falciparum infection who received an ACT in sub-Saharan Africa, 2003–15.

Figure 2

ACT coverage for sub-Saharan Africa (A), stratified by UN subregion (B), and by presence or absence of an AMFm scheme (C). Southern Africa is not included in the graph because all countries other than Namibia had a mean P falciparum prevalence in children aged 2–10 years of less than 2%. Namibia was included in central Africa because its endemic area is at the same latitude as countries in this region. Dotted lines show 95% CI. ACT=artemisinin-based combination therapy. AMFm=Affordable Medicines Facility, malaria.